MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update

Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. RVVTF is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA toward IND-enabling studies, supported by an exclusive supply deal with PharmaAla Biotech Holdings Inc. for the latter’s GMP-MDMA “LaNeo.”

The research is being led by Revive’s partner, PharmaTher Holdings PHRRF, which has completed a non-clinical study with Terasaki Institute for Biomedical Innovation (TIBI), the results of which will soon be shared. 

PharmaTher will finalize the product and clinical development plan after which both partners will start regulatory discussions for studies on several health indications as well as perform required studies towards commercialization in Australia.

The new MDMA patch, according to CEO Michael Frank, will enable flexible drug load capacity and combinations, delivering the psychedelic in a controlled and safe manner. It will potentially overcome obstacles associated with oral dosing and expand “the therapeutic utility of MDMA for mental health and abuse disorders.”

In addition to delivering MDMA, the transdermal patch is also being assessed for psilocybin, a psychedelic for which Revive is furthermore developing a novel oral thin film.

Benzinga’s PCC

Benzinga’s Psychedelics Capital Conference is almost here! 

April 13th at the Fontainebleau Miami Beach Hotel will be THE place to set up deals, raise money, meet investors and key partners and learn from the industry’s greatest.

Get your tickets now!

Photo: Benzinga edit with photo by psychedelic DyrElena by Shutterstock and Wikimedia Commons.

Posted In: CannabisNewsPenny StocksPsychedelicsMarketsAustralia PsychedelicsDrug Delivery TechnologiesMDMA-assisted therapy
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...